Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide MDI in children with persistent asthma
NCT00392288Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Forced Expiratory Volume in One Second at 12 weeks. Started Sep 2006; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00392288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392288.